Home » 90-year grandmother first to receive Pfizer COVID-19 vaccine in Britain
Coronavirus COVID-19 Europe Headlines News

90-year grandmother first to receive Pfizer COVID-19 vaccine in Britain

A 90-year-old British grandmother became the first person in a Western country to receive an approved Coronavirus vaccine, as Britain rolled out  Pfizer-BioNTech’s drug in the biggest inoculation drive in its history.

Margaret Keenan, who turns 91 next week, said it was “the best early birthday present.”

“My advice to anyone offered the vaccine is to take it. If I can have it at 90 then you can have it too,” she said.

Keenan received the jab in front of cameras at a hospital in the central English city of Coventry, followed by an elderly man called William Shakespeare.

“I feel so privileged to be the first person vaccinated against COVID-19,” said Keenan, a former jewellery shop worker who has two children and four grandchildren.

The jab was administered by May Parsons, a nurse originally from the Philippines who has worked for Britain’s state-run National Health Service (NHS) for 23 years.

A second jab is required in 21 days.

Prime Minister Boris Johnson, who spent days in intensive care with COVID-19 earlier this year, called it a “huge step forward in the UK’s fight against coronavirus”.

The head of the state-run National Health Service in England, Simon Stevens, said it was a “decisive turning point” against the “greatest health challenge” since the NHS was founded in 1948.

Britain last week became the first country to approve the Pfizer-BioNTech vaccine, raising hopes of a breakthrough in the pandemic, which has killed more than 1.5 million worldwide.

Britain has been one of the worst-affected countries in the world, with more than 61,000 deaths in the outbreak from 1.6 million cases.

Regulatory approval for the vaccine was given last Wednesday, sparking a race against time to prepare scores of vaccination centres across the country.

The UK has ordered 40 million doses of the jab — enough to vaccinate 20 million people — with 800,000 in the first batch.

Up to four million doses are expected by the end of December.

Leave a Comment

%d bloggers like this: